Vascular endothelial growth factor (VEGF) is now known to play a central role in the vascular changes associated with the leading causes of blindness in developed countries, namely age-related macular degeneration (AMD), diabetic retinopathy and retinal vein occlusions (RVOs) [1,2,3]. The gene discussed is VEGFA; the disease is retinal vein occlusion.